Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$28.4B
1-Year Return
37.22%
This Quarter Return
-14.29%
1 Year Return
+37.22%
3 Year Return
+93.7%
5 Year Return
+199.54%
10 Year Return
+398.51%
AUM
$16.5B
AUM Growth
-$3.93B
(-19%)
Cap. Flow
-$694M
Cap. Flow
% of AUM
-4.21%
Top 10 Holdings %
Top 10 Hldgs %
32.53%
Holding
1,265
New
250
Increased
403
Reduced
360
Closed
243
Top Buys
| 1 |
Canadian National Railway
CNI
|
$83.7M |
| 2 |
Restaurant Brands International
QSR
|
$59.5M |
| 3 |
Brookfield Infrastructure Partners
BIP
|
$57.7M |
| 4 |
AstraZeneca
AZN
|
$55.8M |
| 5 |
Algonquin Power & Utilities
AQN
|
$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$95M |
| 3 |
VRN
Veren
VRN
|
$81.5M |
| 4 |
Wheaton Precious Metals
WPM
|
$73.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$72.5M |
Sector Composition
| 1 | Financials | 27.58% |
| 2 | Energy | 14.57% |
| 3 | Industrials | 13.16% |
| 4 | Technology | 10.16% |
| 5 | Materials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHL
926
DELISTED
Greenhill & Co., Inc.
GHL
| $211K | ﹤0.01% |
22,853
-13,403
| -37% | -$124K |
|
927
Krystal Biotech
KRYS
$4.35B
| $210K | ﹤0.01% |
+3,202
| New | +$210K |
|
928
SI-BONE Inc
SIBN
$703M
| $210K | ﹤0.01% |
15,937
+5,559
| +54% | +$73.3K |
|
929
Cartesian Therapeutics
RNAC
$277M
| $208K | ﹤0.01% |
5,296
-6,496
| -55% | -$255K |
|
930
Princeton Bancorp
BPRN
$223M
| $207K | ﹤0.01% |
7,537
-1,992
| -21% | -$54.7K |
|
931
Emerson Electric
EMR
$74.6B
| $207K | ﹤0.01% |
+2,600
| New | +$207K |
|
932
Karyopharm Therapeutics
KPTI
$57.2M
| $207K | ﹤0.01% |
+3,065
| New | +$207K |
|
|
CFMS
933
DELISTED
Conformis, Inc. Common Stock
CFMS
| $206K | ﹤0.01% |
23,297
-1,830
| -7% | -$16.2K |
|
934
Weibo
WB
$2.87B
| $204K | ﹤0.01% |
+8,805
| New | +$204K |
|
935
Perdoceo Education
PRDO
$2.14B
| $201K | ﹤0.01% |
+17,035
| New | +$201K |
|
936
SL Green Realty
SLG
$4.4B
| $201K | ﹤0.01% |
+4,348
| New | +$201K |
|
937
Hecla Mining
HL
$6.04B
| $196K | ﹤0.01% |
+50,027
| New | +$196K |
|
|
GTHX
938
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $196K | ﹤0.01% |
+39,658
| New | +$196K |
|
939
Quad
QUAD
$334M
| $194K | ﹤0.01% |
70,539
-91,832
| -57% | -$253K |
|
|
DOC
940
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $188K | ﹤0.01% |
+10,793
| New | +$188K |
|
941
Replimune Group
REPL
$494M
| $187K | ﹤0.01% |
+10,718
| New | +$187K |
|
942
Turkcell
TKC
$4.83B
| $186K | ﹤0.01% |
74,557
+12,294
| +20% | +$30.7K |
|
943
Seres Therapeutics
MCRB
$169M
| $182K | ﹤0.01% |
2,650
-6,154
| -70% | -$423K |
|
944
DURECT Corp
DRRX
$59.3M
| $179K | ﹤0.01% |
37,425
+29,552
| +375% | +$141K |
|
|
CONN
945
DELISTED
Conn's Inc.
CONN
| $177K | ﹤0.01% |
+22,061
| New | +$177K |
|
946
Grifois
GRFS
$6.89B
| $173K | ﹤0.01% |
14,543
-20,548
| -59% | -$244K |
|
947
OP Bancorp
OPBK
$212M
| $170K | ﹤0.01% |
16,178
-3,089
| -16% | -$32.5K |
|
948
Precigen
PGEN
$1.3B
| $170K | ﹤0.01% |
127,039
+96,454
| +315% | +$129K |
|
949
Banco Santander
SAN
$141B
| $170K | ﹤0.01% |
60,690
-1,416,356
| -96% | -$3.97M |
|
950
Anavex Life Sciences
AVXL
$807M
| $169K | ﹤0.01% |
+16,922
| New | +$169K |
|